According to Astellas Pharma's latest financial reports the company's total assets are NZ$41.24 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-03-31 | NZ$39.51 B | 34.33% |
2023-03-31 | NZ$29.41 B | 7.27% |
2022-03-31 | NZ$27.42 B | -6.98% |
2021-03-31 | NZ$29.47 B | -17.33% |
2020-03-31 | NZ$35.65 B | 41.87% |
2019-03-31 | NZ$25.13 B | 4.11% |
2018-03-31 | NZ$24.14 B | 4.18% |
2017-03-31 | NZ$23.17 B | -0.1% |
2016-03-31 | NZ$23.19 B | 16.43% |
2015-03-31 | NZ$19.92 B | 7.5% |
2014-03-31 | NZ$18.53 B | -6.54% |
2013-03-31 | NZ$19.83 B | -10.73% |
2012-03-31 | NZ$22.21 B | 5.43% |
2011-03-31 | NZ$21.06 B | 2.12% |
2010-03-31 | NZ$20.63 B | -15.17% |
2009-03-31 | NZ$24.32 B | 32.45% |
2008-03-31 | NZ$18.36 B | 5.21% |
2007-03-31 | NZ$17.45 B | -20.37% |
2006-03-31 | NZ$21.91 B | 83.15% |
2005-03-31 | NZ$11.96 B | -7.89% |
2004-03-31 | NZ$12.99 B |